Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 5/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | TET3 | O43151 | 1/20 | 0.30 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811273 | 0.79 | TET2 (0.36) | TET2TET3TET1 | |
| SCHEMBL8677645 | 0.77 | TET2 (0.33) | TET2 | |
| SCHEMBL5178000 | 0.75 | TET2 (0.33) | TET2 | |
| SCHEMBL810647 | 0.71 | TET2 (0.31) | TET2 | |
| SCHEMBL2722976 | 0.69 | — | — | |
| Methacrylic Acid SCHEMBL27495155 | 0.69 | TET2 (0.39) | TET2LMNAALDH1A1OR51E2 | |
| Methacrylic Acid SCHEMBL28170966 | 0.69 | TET2 (0.39) | TET2LMNAALDH1A1OR51E2 | |
| Glycerin SCHEMBL8658278 | 0.69 | LMNA (0.53) | TET2LMNAALDH1A1OR51E2TET3 | |
| SCHEMBL676152 | 0.69 | TET2 (0.37) | TET2ALDH1A1 | |
| SCHEMBL14354020 | 0.68 | ARG2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | disclosed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-3052140-B1 | NON-SELF-ADHERENT COATING MATERIALS | ROCHAL IND LLC (US) | 2019-05-01 | — | — | EP | disclosed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | disclosed |
| EP-3220741-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-3052140-A1 | NON-SELF-ADHERENT COATING MATERIALS | Rochal Industries, LLC (US) | 2016-08-10 | — | — | EP | disclosed |
| US-20160095876-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2016-04-07 | — | — | US | disclosed |
| WO-2016054021-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLC (US) | 2016-04-07 | — | — | WO | disclosed |
| WO-2015050682-A1 | NON-SELF-ADHERENT COATING MATERIALS | ROCHAL INDUSTRIES, LLP (US) | 2015-04-09 | — | — | WO | disclosed |
| US-8877882-B1 | Non-self-adherent coating materials | ROCHAL INDUSTRIES LLP (US) | 2014-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160095876-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | CUTA, MMP8, MMP1 | TET2 4764/4885LMNA 1246/4885ALDH1A1 4115/4885 |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | TET2 4764/4885LMNA 1237/4885ALDH1A1 4110/4885 |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | TET2 4764/4885LMNA 1237/4885ALDH1A1 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.